Chemotherapy plus durvalumab combinations show promise in advanced biliary tract cancer
Gemcitabine and cisplatin plus durvalumab, with or without tremelimumab, produced favorable outcomes as first-line treatment for advanced biliary tract cancer, according to research.“Immune checkpoint inhibitors…